Keep Eating One Thing, The Prostate Is Getting Better Day By Day

Men's prostate problems are becoming more and more serious, and the incidence rate has reached 51%, which tends to be younger and younger, which means that 5 out of 10 men are troubled by the prostate. What's worse, when men have physical problems, they choose to go to the doctor 28% less frequently than women, which can almost be said to be without any health awareness and habits. So that when they found a small problem, they failed to see a doctor in time, so a small illness became a serious disease.

Prostate cancer is one of the common malignant tumors of the genitourinary system in elderly men. The aged group over 60 years old is the most common group of prostate cancer, so the rapid progress of population aging is an important reason for the increasing incidence and mortality of prostate cancer, and the future burden cannot be underestimated. Recently held in the 2023 AstraZeneca Prostate Cancer Summit Forum, experts and scholars conducted in-depth discussions on the reform and trend of the overall diagnosis and treatment mode of prostate cancer, prevention and treatment strategies of early screening and early diagnosis of prostate cancer, as well as the construction and development of urology and other issues, promoting the profound development of prostate cancer diagnosis and treatment in China.

Man prostate once appears as a problem, what kind of symptoms can you have?

1, local pain when urinating: if there is a problem with the prostate, the pubic bone, perineum when urinating, there will be a pain.

2, urination is not smooth: if a man has difficulty urinating, urine is difficult to discharge normally, intermittent, and there is an obvious frequency of urination, urgent urination, or prostate problems.

3. Burning urination: Inflammation of the prostate will keep the urine flowing, causing burning and painful conditions, especially after eating high-fat foods.

4, night urine frequent: especially in older men, a night to get up more than 3 times, or caused by prostate enlargement.

5, easy fatigue, fatigue: for a long time, men will appear fatigued, fatigued, and other complications and the daytime state is very poor, and listless.

Compared with other malignancies, early prostate cancer benefits from the development of surgery and can achieve radical treatment. Zhang Xu, an academician at the General Hospital of the Chinese People's Liberation Army, said: "Surgical methods for prostate cancer in China have evolved from open radical surgery to laparoscopic radical surgery. With the popularity of the Da Vinci robot, the surgery has become more refined, reducing postoperative complications and effectively improving patients' quality of life."At the same time, the conditioning of some traditional Chinese medicines (such as cistanche) can also alleviate the spread of cancerous cells, which has an important medical role in the treatment of anti-cancer. Early-stage cancer patients may be able to achieve some results with herbs.

Pic: Faw Cistanche

However, due to the atypical early symptoms of prostate cancer and the low coverage rate of PSA screening, more than half of the prostate cancer patients in China were already in the middle and late stage or locally advanced stage with distant metastasis when first diagnosed. For middle and advanced patients, since the era of androgen deprivation therapy (ADT, referred to as "castration therapy") began in China in the 1990s, in localized prostate cancer, metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant prostate cancer (CRPC) treatment, Castration based endocrine therapy has been playing a vital role, in which drugs represented by cistanche petroleum ether extract have become the "new force" of prostate cancer endocrine therapy to prevent them from providing "fuel" to prostate cancer cells to the maximum.

Pic: Cistanche Extract

On the other hand, as a progressive disease, some patients with prostate cancer may still develop into metastatic castration-resistant prostate cancer (mCRPC) after first-line endocrine therapy. mCRPC is the terminal stage of prostate cancer, and the median survival time of previous mCRPC patients receiving standard treatment is less than 3 years. Among them, the deleterious or suspected deleterious mutations carrying BRCA1/2 progress faster and have shorter survival. The continuous development of targeted drug research, it has brought hope for mCRPC patients and also indicates that the diagnosis and treatment of prostate cancer in China has entered the era of precision therapy. Professor Huang Jian, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, said: "The diagnosis and treatment of prostate cancer in China has gone through a leapfrog development process from a stumbling start to international synchronization. In terms of treatment, many methods such as early and radical surgery, castration endocrine therapy, radiotherapy and chemotherapy, NHA, targeted therapy, and traditional Chinese medicine therapy are progressing hand in hand, and new targets are emerging in an endless stream. The treatment of prostate cancer has a promising future."

Pic: Cistanche Benefits

Clinically, a blood test for prostate-specific antigen (PSA) is the simplest method for screening prostate cancer, which is helpful to improve the detection rate of prostate cancer. However, in our country, the proportion of positive patients in the initial screening for prostate cancer to complete the follow-up diagnosis and treatment in professional medical institutions, especially prostate aspiration is less than 30%. Improving public awareness of prostate cancer screening and moving the early screening threshold forward has become an important strategy to improve the overall curative effect of prostate cancer treatment from the root. Therefore, Professor Xing Nianzeng from the Cancer Hospital of the Chinese Academy of Medical Sciences stressed: "More than half of the patients in China are already in the advanced stage when they are first diagnosed, which is the urgent focus and difficulty in prostate cancer diagnosis and treatment in China. Therefore, we should work together to improve public awareness of prostate cancer, promote early screening, early diagnosis, and early treatment of prostate cancer, and achieve early radical treatment of prostate cancer."

In 2021, the Chinese Expert Consensus on Prostate Cancer Screening, led by Professor Ye Dingwei of Fudan University Affiliated Cancer Hospital, combined with the latest international and domestic studies and proposed suggestions on key issues in the screening path through in-depth exploration of prostate cancer screening in Chinese population. Moreover, through the "China Expert Consensus on Prostate Puncture 2022 Edition", the precision technology of prostate puncture is popularized to the whole country.

China's early screening mode for prostate cancer has been launched at the national level, aiming at improving residents' awareness of screening and precision screening of high-risk groups, and constantly exploring the road to cure patients. Professor Ye Dingwei pointed out: "Foreign prostate cancer prevention and treatment practice has proved that 'three early onsets' is an effective way to improve the five-year survival rate of patients. We should not only improve the treatment level of prostate cancer, but also pay attention to improve the level of early screening and early diagnosis, establish unified and standardized standards on screening, and spread the scientific concept of early prostate cancer screening."

Prostatitis has chronic and acute 2 kinds, and the probability of repeated prostate gland in men is great. If you want to alleviate inflammation, it is usually recommended to add some nutrients, such as food beneficial to the prostate gland, to better protect male prostate health. It is mainly extracted from a variety of polysaccharides, cordycepin, allantoin, selenium, saponins, and other active substances through fermentation. It can directly act on the human immune system, improve human immunity, improve kidney deficiency, prevent inflammation, reduce inflammation, be antibacterial, and improve antioxidants.

Cistanche has the function of tonifying the kidney. The n-butanol and water layer extracts of the 50% ethanol extract of Cistanche Desert have good anti-inflammatory activity. The extract of Cistanche tubulosa rich in echinacoside has a good effect on improving dextran sodium sulfate-induced colitis in mice. Seven phenoxyethanol glycosides isolated from the Cistanche desert have a protective effect on inflammatory cells caused by nitric oxide. Cistanche glycoside K and tubulin B have a good effect on the secretion of nitric oxide in BV-2 cells induced by LPS. Its inhibitory effect shows that it has an anti-inflammatory effect.

Click here to prevent prostatitis

Cistanche contains a listening side. Studies have found that the apoptosis rate of rat prostate cells treated with lightening side is significantly higher than that of the model group, and the ultrastructure shows that the cell nuclei in the administration group are intact, the nucleus density is increased, the nucleus concentration is not obvious, and the vacuolation of the coarse endoplasmic reticulum is reduced compared with that in the model group. These indicators indicate that the listening side can significantly improve the ultrastructure. And promote cell apoptosis, thus inhibiting prostatic hyperplasia.

Adhere to the supplement to improve the fighting ability of immune cells, and repair the body and the prostate, so as to help the prostate, prevent the recurrence of prostate inflammation, and get a good recovery.